Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

556 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.
Hudis C, Swanton C, Janjigian YY, Lee R, Sutherland S, Lehman R, Chandarlapaty S, Hamilton N, Gajria D, Knowles J, Shah J, Shannon K, Tetteh E, Sullivan DM, Moreno C, Yan L, Han HS. Hudis C, et al. Among authors: hamilton n. Breast Cancer Res. 2013 Nov 19;15(6):R110. doi: 10.1186/bcr3577. Breast Cancer Res. 2013. PMID: 24252402 Free PMC article. Clinical Trial.
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Dang C, Iyengar N, Datko F, D'Andrea G, Theodoulou M, Dickler M, Goldfarb S, Lake D, Fasano J, Fornier M, Gilewski T, Modi S, Gajria D, Moynahan ME, Hamilton N, Patil S, Jochelson M, Norton L, Baselga J, Hudis C. Dang C, et al. Among authors: hamilton n. J Clin Oncol. 2015 Feb 10;33(5):442-7. doi: 10.1200/JCO.2014.57.1745. Epub 2014 Dec 29. J Clin Oncol. 2015. PMID: 25547504 Free PMC article. Clinical Trial.
High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J, Vahdat L, Fennelly D, Francis P, Wasserheit C, Hudis C, Kritz A, Schneider J, Hamilton N, Gilewski T, et al. Crown J, et al. Among authors: hamilton n. Ann N Y Acad Sci. 1993 Nov 30;698:378-88. doi: 10.1111/j.1749-6632.1993.tb17230.x. Ann N Y Acad Sci. 1993. PMID: 7506505 Review.
High-dose chemotherapy of breast cancer.
Crown J, Raptis G, Hamilton N, Hudis C, Vahclat L, Fennelly D, Norton L. Crown J, et al. Among authors: hamilton n. Can J Oncol. 1995 Dec;5 Suppl 1:80-2. Can J Oncol. 1995. PMID: 8853530 Review.
Carboplatin and etoposide in metastatic breast cancer.
Crown J, Hamilton N, Raptis G, Kritz A, Vahdat L, Norton L. Crown J, et al. Among authors: hamilton n. Ann Oncol. 1995 Apr;6(4):403. doi: 10.1093/oxfordjournals.annonc.a059191. Ann Oncol. 1995. PMID: 7619757 Free article. No abstract available.
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG, et al. Kritz A, et al. Among authors: hamilton n. Cancer. 1993 Apr 15;71(8):2515-21. doi: 10.1002/1097-0142(19930415)71:8<2515::aid-cncr2820710814>3.0.co;2-2. Cancer. 1993. PMID: 8095854 Clinical Trial.
556 results